Affective Analgesia Following Muscarinic Activation of the Ventral Tegmental Area in Rats

Journal of Pain

Volumn 9, Issue 7, 2008, Pages 597-605

  Kender, Robert G ^a   Harte, Steven E ^a   Munn, Elizabeth M ^a   Borszcz, George S ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acetylcholine; carbachol; emotion; muscarinic receptors; reinforcement; Ventral tegmental area; vocalization

Indexed keywords

ATROPINE; CARBACHOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT;

AFTERDISCHARGE; ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; MOOD DISORDER; NERVE CELL; NEUROBIOLOGY; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN THRESHOLD; RAT; RECEPTOR UPREGULATION; REINFORCEMENT; VENTRAL TEGMENTUM; VOCALIZATION;

ANALGESICS, NON-NARCOTIC; ANIMALS; ATROPINE; BEHAVIOR, ANIMAL; CARBACHOL; CHOLINERGIC AGENTS; CHOLINERGIC AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; MALE; MICROINJECTIONS; MUSCARINIC ANTAGONISTS; PAIN MEASUREMENT; PAIN THRESHOLD; PROSENCEPHALON; RATS; RATS, LONG-EVANS; REACTION TIME; REFLEX; REINFORCEMENT (PSYCHOLOGY); SPINAL CORD; TAIL; VENTRAL TEGMENTAL AREA; VOCALIZATION, ANIMAL;

EID: 45549095088     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2008.01.334     Document Type: Article

References (59)

1. Altier N., and Stewart J. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine. J Pharmacol Exp Ther 285 (1998) 208-215
2. Altier N., and Stewart J. The role of dopamine in the nucleus accumbens in analgesia. Life Sci 65 (1999) 2269-2287
3. Asan E. The catecholaminergic innervation of the rat amygdala. Adv Anat Embryol Cell Biol 142 (1998) 1-118
4. Basile A.S., Fedorova I., Zapata A., Liu X., Shippenberg T., Duttaroy A., Yamada M., and Wess J. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci U S A 99 (2002) 11452-11457
5. Borszcz G.S. The capacity of motor reflex and vocalization thresholds to support avoidance conditioning in the rat. Behav Neurosci 107 (1993) 678-693
6. Borszcz G.S. Pavlovian conditional vocalizations of the rat: A model system for analyzing the fear of pain. Behav Neurosci 109 (1995) 648-662
7. Borszcz G.S. Increases in vocalization and motor reflex thresholds are influenced by the site of morphine microinjection: Comparisons following administration into the periaqueductal gray, ventral medulla, and spinal subarachnoid space. Behav Neurosci 109 (1995) 502-522
8. Borszcz G.S. Differential contributions of medullary, thalamic, and amygdaloid serotonin to the antinociceptive action of morphine administered into the periaqueductal gray: A model of morphine analgesia. Behav Neurosci 113 (1999) 612-631
9. Borszcz G.S. Contribution of the ventromedial hypothalamus to generation of the affective dimension of pain. Pain 123 (2006) 155-168
10. Borszcz G.S., Johnson C.P., Anderson M.E., and Young B.J. Characterization of tail shock elicited withdrawal reflexes in intact and spinal rats. Physiol Behav 52 (1992) 1055-1062
11. Borszcz G.S., Johnson C.P., and Fahey K.A. Comparison of motor reflex and vocalization thresholds following systemically administered morphine, fentanyl, and diazepam in the rat: assessment of sensory and performance variables. Pharmacol Biochem Behav 49 (1994) 827-834
12. Borszcz G.S., Johnson C.P., and Thorp M.V. The differential contribution of spinopetal projections to increases in vocalization and motor reflex thresholds generated by the microinjection of morphine into the periaqueductal gray. Behav Neurosci 110 (1996) 368-388
13. Borszcz G.S., Johnson C.P., and Williams D.H. Increases in vocalization and motor reflex thresholds generated by the intrathecal administration of serotonin or norepinephrine. Behav Neurosci 110 (1996) 809-822
14. Borszcz G.S., and Leaton R.N. The effect of amygdala lesions on conditional and unconditional vocalizations in rats. Neurobiol Learn Memory 79 (2003) 212-225
15. Calabresi P., Lacey M.G., and North R.A. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98 (1989) 135-140
16. Carroll M.N., and Lim K.S. Observations on the neuropharmacology of morphine and morphine-like analgesia. Arch Int Pharmacodyn Ther 125 (1960) 383-403
17. Eglen R.M., Choppin A., and Watson N. Therapeutic opportunities from muscarinic receptor research. Trends Pharmacol Sci 22 (2001) 409-414
18. Fanselow M.S. Odors released by stressed rats produce opioid analgesia in unstressed rats. Behav Neurosci 99 (1985) 589-592
19. Forster G.L., and Blaha C.D. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area. Eur J Neurosci 12 (2000) 3596-3604
20. Forster G.L., Yeomans J.S., Takeuchi J., and Blaha C.D. M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22 (2002) RC190
21. Franklin K.B.J. Analgesia and the neural substrate of reward. Neurosci Biobehav Rev 13 (1989) 149-154
22. Franklin K.B.J. Analgesia and abuse potential: An accidental association or a common substrate. Pharmacol Biochem Behav 59 (1998) 993-1002
23. Gear R.W., Aley K.O., and Levine J.D. Pain-induced analgesia mediated by mesolimbic reward circuits. J Neurosci 19 (1999) 7175-7181
24. Gracely R.H., McGrath P., and Dubner R. Validity and sensitivity of ratio scales of sensory and affective verbal pain descriptors: Manipulation of affect by diazepam. Pain 5 (1978) 19-29
25. Gronier B., and Rasmussen K. Activation of midbrain presumed dopaminergic neurons by muscarinic cholinergic receptors: An in vivo electrophysiological study in the rat. Br J Pharmacol 124 (1998) 455-464
26. Harte S.E., Kender R.G., and Borszcz G.S. Activation of 5-HT1A and 5-HT7 receptors in the parafascicular nucleus suppresses the affective reaction of rats to noxious stimulation. Pain 113 (2005) 405-415
27. Harte S.E., Lagman A.L., and Borszcz G.S. Antinociceptive effects of morphine injected into the nucleus parafascicularis thalami of the rat. Brain Res 874 (2000) 78-86
28. Helmstetter F.J., Tershner S.A., Poore L.H., and Bellgowan P.S. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res 779 (1998) 104-118
29. Ikemoto S. Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56 (2007) 27-78
30. Ikemoto S., and Wise R.A. Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 22 (2002) 9895-9904
31. LaBuda C.J., and Fuchs P.N. Attenuation of negative pain affect produced by unilateral spinal nerve injury in the rat following anterior cingulate cortex activation. Neuroscience 136 (2005) 311-322
32. Lacey M.G., Calabresi P., and North R.A. Muscarine depolarizes rat substantia nigra zona compacta and ventral tegmental neurons in vitro through M1-like receptors. J Pharmacol Exp Ther 253 (1990) 395-400
33. Lopez-Avila A., Coffeen U., Ortega-Legaspi J.M., del Angel R., and Pellicer F. Dopamine and NMDA systems modulate long-term nociception in the rat anterior cingulate cortex. Pain 111 (2004) 136-143
34. Manning B.H., Morgan M.J., and Franklin K.B.J. Morphine analgesia in the formalin test: Evidence for forebrain and midbrain sites of action. Neuroscience 63 (1994) 289-294
35. Mantz J., Milla C., Glowinski J., and Thierry A.M. Differential effects of ascending neurons containing dopamine and noradrenaline in the control of spontaneous activity and of evoked responses in the rat prefrontal cortex. Neuroscience 27 (1988) 517-526
36. Mark V.H., Ervin F.R., and Yakovlev P.I. The treatment of pain by stereotaxic methods, Confinia. Neurologica 22 (1962) 238-245
37. Melzack R. The tragedy of needless pain. Sci Am 262 (1990) 27-33
38. Miller A.D., Forster G.L., Yeomans J.S., and Blaha C.D. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat. Neuroscience 136 (2005) 531-538
39. Morgan M.J., and Franklin K.B.J. 6-Hydroxydopamine lesions of the ventral tegmentum abolish D-amphetamine and morphine analgesia in the formalin test but not in the tail flick test. Brain Res 519 (1990) 144-149
40. Nandigama P., and Borszcz G.S. Affective analgesia following the administration of morphine into the amygdala of rats. Brain Res 959 (2003) 343-354
41. Nisell M., Nomikos G.G., and Svensson T.H. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75 (1994) 348-352
42. Oades R.D., and Halliday G.M. Ventral tegmental (A10) system: Neurobiology, 1: Anatomy and connectivity. Brain Res 434 (1987) 117-165
43. Oberst F. Symposium: Can the euphoric, analgetic and physical dependence of drugs be separated?. Fed Am Soc Exp Biol Proc 2 (1943) 187-203
44. Omelchenko N., and Sesack S.R. Laterodorsal tegmental projections to identified cell populations in the rat ventral tegmental area. J Comp Neurol 483 (2005) 217-235
45. Onn S.P., and Wang X.B. Differential modulation of anterior cingulate cortical activity by afferents from ventral tegmental area and mediodorsal thalamus. Eur J Neurosci 21 (2005) 2975-2992
46. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, New York, NY
47. Price D.D., Von der Gruen A., Miller J., Rafii A., and Price C. A psychophysical analysis of morphine analgesia. Pain 22 (1985) 261-269
48. Rada P.V., Mark G.P., Yeomans J.S., and Hoebel B.G. Acetylcholine release in ventral tegmental area by hypothalamic self-stimulation, eating, and drinking. Pharmacol Biochem Behav 65 (2000) 375-379
49. Redgrave P., and Horrell R.I. Potentiation of central reward by localised perfusion of acetylcholine and 5-hydroxytryptamine. Nature 262 (1976) 305-307
50. Suzuki T., Kishimoto Y., and Misawa M. Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci 59 (1996) 1667-1674
51. Sweet W.H. Central mechanisms of chronic pain (neuralgias and certain other neurogenic pain). In: Bonica J.J. (Ed). Pain (1980), Raven Press, New York, NY 287-303
52. Vaccarino A.L., Marek P., Kest B., Ben-Eliyahu S., Couret Jr. L.C., Kao B., and Liebeskind J.C. Morphine fails to produce tolerance when administered in the presence of formalin pain in rats. Brain Res 627 (1993) 287-290
53. Vilaro M.T., Palacios J.M., and Mengod G. Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114 (1990) 154-159
54. Westerink B.H., Enrico P., Feimann J., and deVries J.B. The pharmacology of mesocortical dopamine neurons: A dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther 285 (1998) 143-154
55. Williams M., and Robinson J.L. Nicotinic receptors in mammalian brain. Prog Neuropsychopharmacol Biol Psychiatry 8 (1984) 769-772
56. Wise R.A., and Rompre P.P. Brain dopamine and reward. Ann Rev Psychol 40 (1989) 191-225
57. Yeomans J.S., and Baptista M. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57 (1997) 915-921
58. Yeomans J.S., Forster G., and Blaha C. M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68 (2001) 2449-2456
59. Yeomans J.S., Kofman O., and McFarlane V. Cholinergic involvement in lateral hypothalamic rewarding brain stimulation. Brain Res 329 (1985) 19-26